Exploring tissue engineering to improve kidney and urologic health
Official title: Tissue Engineering and Regenerative Medicine Undergraduate Research Addressing Challenges in Kidney and Urologic Diseases
Funded at Wake Forest University Health Sciences · NIH-10886768 · Data updated 2026-11-12
This summer program invites undergraduate students, especially those from under-represented backgrounds, to dive into exciting research about improving treatments for kidney and urinary diseases, while learning from experienced mentors and building skills for their future careers in science.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wake Forest University Health Sciences NIH-funded |
| Lab location | 1 site (Winston-Salem, United States) |
| Project start | September 20, 2022 |
| Project end | June 30, 2027 |
| Funding year | 2024 |
| Award (this year) | $107,996 |
| NIH project number | 5R25DK126625-03 |
| Project ID | NIH-10886768 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are undergraduate students, particularly those from under-represented minority groups and first-generation college students interested in biomedical research.
✕Less likely to help
Patients who are not undergraduate students or who do not have an interest in pursuing a career in biomedical research may not benefit from this research.
What this research studies
This research program offers undergraduate students a unique opportunity to engage in multidisciplinary research focused on tissue engineering and regenerative medicine aimed at addressing kidney and urologic diseases. Over a 10-week summer program, students will work alongside faculty and graduate mentors to develop skills and knowledge in this critical area of biomedical research. The program emphasizes diversity and inclusion, targeting under-represented groups and first-generation college students to enhance their participation in scientific research. Participants will also engage in educational workshops and evaluations to support their career development in the biomedical field.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments and preventive strategies for kidney and urologic diseases, ultimately improving patient outcomes.
How similar studies have gone: Similar educational and research initiatives have shown success in enhancing diversity and improving outcomes in biomedical research fields.
Where this research is happening
-
Wake Forest University Health Sciences
Winston-Salem, United States Active
Researchers
- Principal investigator: Opara, Emmanuel C. — Wake Forest University Health Sciences
- Study coordinator: Opara, Emmanuel C.
Related research
Other NIH-funded projects on the same topics.
-
Urine, perineal, and stool microbiota in children and adolescents
We will test whether the bacteria in voided urine, around the genitals, and in stool differ between children with overactive bladder or daytime wetting and healthy children of the same age and gender.
-
21-day comprehensive spa care for kidney and urinary conditions
This program will try a 21-day spa treatment with mineral water baths, drinking cures, exercise and diet for adults 40–70 who have chronic kidney or urinary problems to see if it improves symptoms and kidney health.
-
Hospital admissions for blood in the urine
This international observational project will look at how hospitals manage adults admitted with blood in the urine to see which approaches lead to shorter stays and better outcomes.
-
Using AI language models to help diagnose and recommend treatments for urologic conditions
This project will test whether three AI language models (ChatGPT, Gemini, DeepSeek) can accurately recognize urologic diseases and suggest diagnoses and treatments from archived hospital records of adult patients.
-
Virtual reality to reduce pain and anxiety during outpatient urology procedures
This trial will try a virtual reality headset (REALICA®) to reduce pain and anxiety for adults having outpatient urology procedures such as circumcision, prostate biopsy, or flexible cystoscopy.
-
Using vorolanib for treating advanced kidney cancer
This study is testing if the drug vorolanib can help people with advanced kidney cancer live longer when used as a second treatment option.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.